UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021680
Receipt number R000025007
Scientific Title The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery
Date of disclosure of the study information 2016/04/25
Last modified on 2017/02/13 10:35:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery

Acronym

The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery

Scientific Title

The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery

Scientific Title:Acronym

The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery

Region

Japan


Condition

Condition

Acute aortic disection
Thoracic aortic aneurysm
re-cardio-vascular surgery

Classification by specialty

Anesthesiology Cardiovascular surgery Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The evaluation of coagulation ability at leaving cardio-pulmonary bypass

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

result of thromboelastography after leaving cardio pulmonary bypass and administrating protamine

Key secondary outcomes

relationship with other blood examination
total of bleeding
amount of postoperative transfusion


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

befor leaving cardio-pulmonary bypass, FFP4Unit is administrated.
after leaving cardio-pulmonary bypass, FFP4Unit is administrated.

Interventions/Control_2

befor leaving cardio-pulmonary bypass, FFP isn't administrated.
after leaving cardio-pulmonary bypass, FFP8Unit is administrated.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Cardiovascular surgery cases with using FFP and/or PC : Acute aortic disection, Thorasic aortic aneurysm, Re-cardiovascular surgery

Key exclusion criteria

incompatibility using FFP, PC, heaprin, protamine
When FFP and PC deviate from the prescribed time.
The patient is judged that joining to this study is inappropriate

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takahiro Tamura

Organization

Japanease red cross nagoya daiichi hospital

Division name

Anesthesiology

Zip code


Address

35, Michisita-cho 3, Nakamura-ku, Nagoya city, Aichi, Japan

TEL

0524815111

Email

takahiro@nagoya-1st.jrc.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takahiro Tamura

Organization

Japanease red cross nagoya daiichi hospital

Division name

Anesthesiology

Zip code


Address

35, Michisita-cho 3, Nakamura-ku, Nagoya city, Aichi, Japan

TEL

0524815111

Homepage URL


Email

takahiro@nagoya-1st.jrc.or.jp


Sponsor or person

Institute

Nagoya university graduste school of medicine

Institute

Department

Personal name



Funding Source

Organization

Japanease red cross nagoya daiichi hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 25 Day

Date of IRB


Anticipated trial start date

2016 Year 04 Month 25 Day

Last follow-up date

2017 Year 02 Month 13 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 30 Day

Last modified on

2017 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025007


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name